Amylyx Pharmaceuticals Inc Financial Overview
Amylyx Pharmaceuticals Inc's market cap is currently $1.32B. The company's EPS TTM is $-0.37; its P/E ratio is -6.95; Amylyx Pharmaceuticals Inc is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.35. See an overview of income statement, balance sheet, and cash flow financials.
